Herbs and plantsHops — a beer flower for insomnia?
- Europejska Agencja Leków (EMA) — Szyszka chmielu — streszczenie EMA dla pacjentów
- Henryk Różański — Strobilus Lupuli et lupulinum, czyli chmiel jako sedativum
- Henryk Różański — Ziołomiody w praktyce
- Henryk Różański — Gruczołki chmielu – Glandulae Lupuli w medycynie XIX i początku XX wieku.
- Herbal and Natural Supplements for Improving Sleep: A Literature Review. · Psychiatry Investig 2024
- Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial. · Brain Behav 2025
- Treating primary insomnia - the efficacy of valerian and hops. · Aust Fam Physician 2010
- Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. · Indian J Pharmacol 2013
- Chemical compositions and sleep-promoting activities of hop (Humulus lupulus L.) varieties. · J Food Sci 2023
- GABAA Receptor-Mediated Sleep-Promoting Effect of Saaz-Saphir Hops Mixture Containing Xanthohumol and Humulone. · Molecules 2021
- Effect of Valerian/Hop Mixture on Sleep-Related Behaviors in Drosophila melanogaster. · Biol Pharm Bull 2017
The European Medicines Agency (EMA) states that preparations made from hop cones may help with sleep and relieve mild nervous tension.
- Long-standing use supports their use, but clinical studies do not allow the effects of hops alone on sleep to be assessed with confidence.
- Studies used hops together with valerian, so no reliable conclusions could be drawn about hops alone.
- Medicines containing hop cones are intended for adults and young people over 12 years of age. If symptoms last longer than two weeks, consult a healthcare professional.
What the authors write
Preparations made from hop cones may help with sleep and relieve mild nervous tension.
Hop cones and lupulin are described as sedatives, sleep aids and anti-anxiety remedies.
Long-standing use supports the use of hops, but clinical studies are not sufficient to reliably confirm the effects of hops alone on sleep.
Clinical studies on sleep used hops together with valerian, so no reliable conclusions could be drawn about hops alone.
Herbal honey with hops, valerian and lemon balm is recommended, among other things, for insomnia.
A tincture made from fresh hop cones has a calming effect.
Water extracts of the cones mainly aid digestion, while the calming components dissolve poorly in water.
Hop oil was taken by mouth as a sedative and mild narcotic.
Hop cone is the common name for the inflorescences of the hop plant.
Medicines containing hop cones are intended for adults and young people over 12 years of age. If symptoms last longer than two weeks, consult a healthcare professional.
Research from PubMed · Europe PMC
We selected 7 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 31.
A review suggests that hops may improve sleep quality and relieve insomnia symptoms, although the strength of the evidence varies.
Aim of the study: Herbal and natural supplements have gained popularity as alternative treatments for insomnia and sleep disorders because they are seen as safe and potentially effective. This literature review summarizes the current evidence on the effectiveness, safety and mechanisms of action of commonly used sleep supplements, including valerian, hops, kava, German chamomile, cherry, tryptophan, theanine, melatonin, magnesium and zinc.
Results: The findings suggest that certain supplements, particularly valerian, hops and melatonin, may improve sleep quality and reduce insomnia symptoms by affecting neurotransmitter systems and regulating sleep-wake cycles. However, the strength of the evidence varies, and optimal doses, formulations and treatment durations have not been established. Although these supplements are generally considered safe, they are not without risks, such as rare but serious adverse effects associated with kava and possible interactions with prescription medicines. The quality and purity of supplements also vary widely because there are no strict regulations. Healthcare providers should keep up with the latest research and work closely with patients to develop personalized treatment plans.
“Not stated” does not mean nobody paid — the database does not always record it.
In a small study, a combination of valerian and hops increased sleep duration compared with placebo.
Aim of the study: This study evaluated the feasibility of investigating the effect of a valerian- and hops-based herbal medicine (Ze 91019) on daytime cognitive performance, psychological measures and sleep in people with occasional sleep problems.
Results: The study design proved feasible, with high adherence to the study protocol. Exploratory analyses found a statistically significant increase in sleep duration during treatment among participants using Ze 91019 compared with placebo (mean daily increase: 21.7 min, p = 0.019), with no statistically significant effects on cognitive or psychological outcomes. In addition, Ze 91019 statistically significantly increased the sleep duration of the shortest night during treatment by 48.7 minutes. The medicine was well tolerated. The study design proved feasible, and Ze 91019 increased sleep duration without affecting daytime cognitive or psychological outcomes.
“Not stated” does not mean nobody paid — the database does not always record it.
A review links the use of valerian, alone or with hops, to improvements in some sleep measures, but recommends interpreting the findings cautiously.
Aim of the study: To evaluate the effectiveness of valerian and hops in treating primary insomnia.
Results: Further randomized, double-blind, placebo-controlled trials are needed before such herbal treatments can be confidently recommended for treating primary insomnia.
“Not stated” does not mean nobody paid — the database does not always record it.
A combination product containing hops improved sleep duration, time to fall asleep and the number of nighttime awakenings, similarly to zolpidem.
Aim of the study: To assess the effectiveness and safety of NSF-3, a multi-herb sedative and sleep medicine containing standardized extracts of Valeriana officinalis, Passiflora incarnata and Humulus lupulus, compared with zolpidem in primary insomnia.
Results: A total of 91 subjects were recruited, of whom 39 in each group completed the study. Total sleep time, time to fall asleep, the number of nighttime awakenings and insomnia severity index scores improved significantly in both groups. However, there was no statistically significant difference between the groups. Epworth sleepiness scores did not change significantly during the study. Twelve treatment-emergent adverse events were reported with NSF-3 and 16 with zolpidem (the most common was drowsiness in both groups); most were mild, and no serious adverse events occurred. NSF-3 is a safe and effective short-term alternative to zolpidem for primary insomnia. It remains to be studied whether the benefits last and whether long-term use of this formulation can lead to dependence.
“Not stated” does not mean nobody paid — the database does not always record it.
In animal models, some hop extracts increased sleep duration and improved sleep in a model of caffeine-induced insomnia.
Aim of the study: Among natural products that promote sleep, hops have been used since ancient times as a tranquilizer and sleep aid. This study investigated the sleep-promoting effects of extracts from various hop (Humulus lupulus L.) varieties in invertebrate and vertebrate models.
Results: Total sleep time in mice whose sleep was induced with pentobarbital increased significantly with Simcoe and Mosaic water extracts and Saphir and Simcoe ethanol extracts, compared with the normal group. Oral administration of Simcoe water extract and Saphir alcohol extract improved sleep in the caffeine-induced insomnia model and increased mRNA expression of GABAA (gamma 2 subunit) and GABAB receptors in mouse brains. In addition, Saphir alcohol extract significantly increased GABA content in mouse brains. Simcoe water extract and Saphir ethanol extract affected GABAergic signaling and improved sleep-related behaviors, including sleep duration.
“Not stated” does not mean nobody paid — the database does not always record it.
A mixture of two hop varieties increased sleep duration in an animal model of caffeine-induced insomnia.
Aim of the study: Hops contain flavonoids with sedative and sleep-promoting effects, such as α-acid, β-acid and xanthohumol. This study measured the sleep-enhancing activity of a Saaz-Saphir hop mixture.
Results: Because the GABA antagonists picrotoxin and bicuculline reduced sleep activity, this confirmed that the GABAA receptor was involved in the activity of the Saaz-Saphir mixture. In addition, a GABAA receptor antagonist also reduced the sleep activity induced by xanthohumol and humulone in the Saaz-Saphir mixture. Therefore, xanthohumol and humulone in the mixture showed sleep-promoting activity mediated by GABAA receptors. The Saaz and Saphir hop mixture may therefore help reduce sleep disturbances compared with other hop varieties.
“Not stated” does not mean nobody paid — the database does not always record it.
A mixture of valerian and hops extended fruit flies’ sleep, partly even after caffeine was administered.
Aim of the study: The aim of this study was to investigate the sleep-promoting effect of a valerian/hops mixture in fruit flies. HPLC analysis showed that valerian and hops contained valerenic acid (1260.53 µg/g of extract) and xanthohumol (Cascade: 827.49 µg/g, Hallertau: 763.60 µg/g, Saaz: 186.93 µg/g), respectively.
Results: This effect of the mixture was partly seen in caffeine-treated flies. The valerian/Cascade mixture increased mRNA expression of gamma-aminobutyric acid (GABA) receptors and the serotonin receptor, with a stronger effect on GABA receptors than on the serotonin receptor. In a competitive GABA receptor-binding assay, the valerian/Cascade mixture extract showed stronger binding to the GABA receptor than valerenic acid and/or xanthohumol, which are considered active compounds in the extract. This study shows that a valerian/Cascade mixture extract improves sleep-related behaviors, including sleep duration, by affecting GABAergic and serotonergic signaling.
“Not stated” does not mean nobody paid — the database does not always record it.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.